(Total Views: 550)
Posted On: 06/22/2025 7:38:03 AM
Post# of 155734
There he is. Nice!
“In specific aim 1, we will generate and characterize AAV bearing capsids that target T and B cells specifically across both macaques and humans.
https://reporter.nih.gov/project-details/1109...ription“
“In specific aim 1, we will generate and characterize AAV bearing capsids that target T and B cells specifically across both macaques and humans.
https://reporter.nih.gov/project-details/1109...ription“
(5)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
